Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats

K. L. French, Heather Bimonte-Nelson, Ann Charlotte Granholm

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Galantamine is an acetylcholine esterase inhibitor that has been approved for use in Alzheimer's disease. However, even though clinical studies indicate efficacy in attenuating some of the symptoms associated with the disease, there are a paucity of studies evaluating the effects of galantamine administration on cognitive performance and brain parameters in aged rats. Further, because all previous animal studies using galantamine have been performed in male rats, there is no information on how females respond to galantamine treatment. Therefore, we studied the effects of 0.3, 0.6, and 1.2 mg/kg/day galantamine in 20-month-old female rats in terms of performance on the working and reference memory water radial arm maze task. Galantamine did not influence maze performance. Furthermore, a probe trial procedure to determine extra-maze cue utilization while solving the water radial arm maze established that aged female rats utilized extramaze cues, and that they did not rely on a nonspatial chaining strategy to locate hidden platforms. Galantamine treatment had no effect on use of extramaze cues or chaining. In addition, there were no significant changes in neurotrophin levels in the frontal cortex, entorhinal cortex, hippocampus, or basal forebrain after galantamine administration. Therefore, the data reported here suggest that aged animals do utilize spatial strategies for solving a working memory task, but galantamine has no appreciable effects on this task, at least not at the doses tested.

Original languageEnglish (US)
Pages (from-to)197-205
Number of pages9
JournalCell Transplantation
Volume16
Issue number3
StatePublished - 2007

Fingerprint

Galantamine
Nerve Growth Factors
Cues
Rats
Data storage equipment
Animals
Short-Term Memory
Water
Brain
Spatial Memory
Entorhinal Cortex
Frontal Lobe
Esterases
Acetylcholine
Hippocampus
Alzheimer Disease

Keywords

  • Acetylcholine esterase inhibitors
  • Aging
  • Hippocampal tasks
  • Learning and memory
  • Nonspatial strategy
  • Spatial strategy

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats. / French, K. L.; Bimonte-Nelson, Heather; Granholm, Ann Charlotte.

In: Cell Transplantation, Vol. 16, No. 3, 2007, p. 197-205.

Research output: Contribution to journalArticle

@article{ab8b5dc6b9d345e692cf12b104a225ee,
title = "Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats",
abstract = "Galantamine is an acetylcholine esterase inhibitor that has been approved for use in Alzheimer's disease. However, even though clinical studies indicate efficacy in attenuating some of the symptoms associated with the disease, there are a paucity of studies evaluating the effects of galantamine administration on cognitive performance and brain parameters in aged rats. Further, because all previous animal studies using galantamine have been performed in male rats, there is no information on how females respond to galantamine treatment. Therefore, we studied the effects of 0.3, 0.6, and 1.2 mg/kg/day galantamine in 20-month-old female rats in terms of performance on the working and reference memory water radial arm maze task. Galantamine did not influence maze performance. Furthermore, a probe trial procedure to determine extra-maze cue utilization while solving the water radial arm maze established that aged female rats utilized extramaze cues, and that they did not rely on a nonspatial chaining strategy to locate hidden platforms. Galantamine treatment had no effect on use of extramaze cues or chaining. In addition, there were no significant changes in neurotrophin levels in the frontal cortex, entorhinal cortex, hippocampus, or basal forebrain after galantamine administration. Therefore, the data reported here suggest that aged animals do utilize spatial strategies for solving a working memory task, but galantamine has no appreciable effects on this task, at least not at the doses tested.",
keywords = "Acetylcholine esterase inhibitors, Aging, Hippocampal tasks, Learning and memory, Nonspatial strategy, Spatial strategy",
author = "French, {K. L.} and Heather Bimonte-Nelson and Granholm, {Ann Charlotte}",
year = "2007",
language = "English (US)",
volume = "16",
pages = "197--205",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "3",

}

TY - JOUR

T1 - Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats

AU - French, K. L.

AU - Bimonte-Nelson, Heather

AU - Granholm, Ann Charlotte

PY - 2007

Y1 - 2007

N2 - Galantamine is an acetylcholine esterase inhibitor that has been approved for use in Alzheimer's disease. However, even though clinical studies indicate efficacy in attenuating some of the symptoms associated with the disease, there are a paucity of studies evaluating the effects of galantamine administration on cognitive performance and brain parameters in aged rats. Further, because all previous animal studies using galantamine have been performed in male rats, there is no information on how females respond to galantamine treatment. Therefore, we studied the effects of 0.3, 0.6, and 1.2 mg/kg/day galantamine in 20-month-old female rats in terms of performance on the working and reference memory water radial arm maze task. Galantamine did not influence maze performance. Furthermore, a probe trial procedure to determine extra-maze cue utilization while solving the water radial arm maze established that aged female rats utilized extramaze cues, and that they did not rely on a nonspatial chaining strategy to locate hidden platforms. Galantamine treatment had no effect on use of extramaze cues or chaining. In addition, there were no significant changes in neurotrophin levels in the frontal cortex, entorhinal cortex, hippocampus, or basal forebrain after galantamine administration. Therefore, the data reported here suggest that aged animals do utilize spatial strategies for solving a working memory task, but galantamine has no appreciable effects on this task, at least not at the doses tested.

AB - Galantamine is an acetylcholine esterase inhibitor that has been approved for use in Alzheimer's disease. However, even though clinical studies indicate efficacy in attenuating some of the symptoms associated with the disease, there are a paucity of studies evaluating the effects of galantamine administration on cognitive performance and brain parameters in aged rats. Further, because all previous animal studies using galantamine have been performed in male rats, there is no information on how females respond to galantamine treatment. Therefore, we studied the effects of 0.3, 0.6, and 1.2 mg/kg/day galantamine in 20-month-old female rats in terms of performance on the working and reference memory water radial arm maze task. Galantamine did not influence maze performance. Furthermore, a probe trial procedure to determine extra-maze cue utilization while solving the water radial arm maze established that aged female rats utilized extramaze cues, and that they did not rely on a nonspatial chaining strategy to locate hidden platforms. Galantamine treatment had no effect on use of extramaze cues or chaining. In addition, there were no significant changes in neurotrophin levels in the frontal cortex, entorhinal cortex, hippocampus, or basal forebrain after galantamine administration. Therefore, the data reported here suggest that aged animals do utilize spatial strategies for solving a working memory task, but galantamine has no appreciable effects on this task, at least not at the doses tested.

KW - Acetylcholine esterase inhibitors

KW - Aging

KW - Hippocampal tasks

KW - Learning and memory

KW - Nonspatial strategy

KW - Spatial strategy

UR - http://www.scopus.com/inward/record.url?scp=34250626050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250626050&partnerID=8YFLogxK

M3 - Article

C2 - 17503733

AN - SCOPUS:34250626050

VL - 16

SP - 197

EP - 205

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 3

ER -